Concepts (250)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Melanoma | 14 | 2023 | 5508 | 2.550 |
Why?
|
Prurigo | 11 | 2023 | 21 | 2.210 |
Why?
|
Skin Neoplasms | 13 | 2023 | 5691 | 1.770 |
Why?
|
Exanthema | 5 | 2024 | 501 | 1.650 |
Why?
|
Psoriasis | 4 | 2022 | 901 | 1.360 |
Why?
|
Neoplasms | 20 | 2024 | 21675 | 1.310 |
Why?
|
Pruritus | 10 | 2022 | 361 | 1.240 |
Why?
|
International Classification of Diseases | 3 | 2022 | 866 | 1.200 |
Why?
|
Hyperpigmentation | 3 | 2023 | 112 | 1.160 |
Why?
|
Skin | 11 | 2024 | 4372 | 1.010 |
Why?
|
Drug Eruptions | 3 | 2023 | 297 | 0.970 |
Why?
|
Biological Products | 2 | 2021 | 859 | 0.830 |
Why?
|
Melanosis | 1 | 2022 | 78 | 0.820 |
Why?
|
Cochlear Implantation | 3 | 2017 | 310 | 0.760 |
Why?
|
Oncolytic Virotherapy | 2 | 2023 | 498 | 0.750 |
Why?
|
Lymphoma, T-Cell, Cutaneous | 2 | 2020 | 207 | 0.740 |
Why?
|
Skin Diseases | 3 | 2023 | 1066 | 0.730 |
Why?
|
Scalp Dermatoses | 1 | 2020 | 40 | 0.720 |
Why?
|
Paresthesia | 1 | 2020 | 160 | 0.680 |
Why?
|
Alopecia | 2 | 2020 | 382 | 0.670 |
Why?
|
Neurodermatitis | 3 | 2022 | 8 | 0.620 |
Why?
|
Hearing Loss, Sensorineural | 2 | 2013 | 770 | 0.560 |
Why?
|
Antimalarials | 1 | 2023 | 904 | 0.560 |
Why?
|
Pemphigoid, Bullous | 3 | 2022 | 110 | 0.560 |
Why?
|
Arthritis, Psoriatic | 1 | 2019 | 215 | 0.540 |
Why?
|
Vestibular Diseases | 2 | 2015 | 217 | 0.530 |
Why?
|
Rheumatic Diseases | 1 | 2022 | 593 | 0.520 |
Why?
|
Administration, Cutaneous | 5 | 2023 | 710 | 0.520 |
Why?
|
Cohort Studies | 17 | 2024 | 40545 | 0.520 |
Why?
|
Quality-Adjusted Life Years | 5 | 2020 | 1683 | 0.510 |
Why?
|
Retrospective Studies | 30 | 2023 | 77410 | 0.510 |
Why?
|
Mycosis Fungoides | 3 | 2021 | 163 | 0.490 |
Why?
|
Patient Admission | 1 | 2021 | 1380 | 0.450 |
Why?
|
Auditory Diseases, Central | 1 | 2012 | 7 | 0.440 |
Why?
|
Acne Vulgaris | 3 | 2023 | 302 | 0.430 |
Why?
|
Humans | 93 | 2024 | 743811 | 0.420 |
Why?
|
Antirheumatic Agents | 1 | 2022 | 1338 | 0.420 |
Why?
|
Cochlear Implants | 2 | 2017 | 339 | 0.410 |
Why?
|
Immunosuppressive Agents | 2 | 2021 | 4152 | 0.400 |
Why?
|
Pneumonia, Aspiration | 1 | 2012 | 145 | 0.400 |
Why?
|
Hearing Loss | 1 | 2019 | 765 | 0.390 |
Why?
|
Immunotherapy | 12 | 2024 | 4437 | 0.390 |
Why?
|
Quality of Life | 12 | 2023 | 12788 | 0.380 |
Why?
|
Autoimmune Diseases | 1 | 2022 | 2134 | 0.370 |
Why?
|
Seasons | 4 | 2023 | 1493 | 0.360 |
Why?
|
Search Engine | 3 | 2020 | 144 | 0.330 |
Why?
|
Pneumonia, Ventilator-Associated | 1 | 2012 | 274 | 0.330 |
Why?
|
Nutrition Surveys | 4 | 2022 | 1660 | 0.320 |
Why?
|
Acoustic Stimulation | 1 | 2012 | 1209 | 0.310 |
Why?
|
Cognition Disorders | 3 | 2019 | 4041 | 0.300 |
Why?
|
Cross-Sectional Studies | 18 | 2022 | 25032 | 0.300 |
Why?
|
Dermatology | 3 | 2022 | 872 | 0.300 |
Why?
|
Hospital Costs | 2 | 2012 | 985 | 0.280 |
Why?
|
Vertigo | 2 | 2019 | 202 | 0.270 |
Why?
|
United States | 18 | 2022 | 69859 | 0.240 |
Why?
|
Head and Neck Neoplasms | 3 | 2013 | 2736 | 0.240 |
Why?
|
Vestibule, Labyrinth | 2 | 2016 | 235 | 0.230 |
Why?
|
Scleroderma, Localized | 1 | 2023 | 79 | 0.220 |
Why?
|
Erythema Multiforme | 1 | 2022 | 31 | 0.210 |
Why?
|
Pyridoxine | 1 | 2022 | 102 | 0.210 |
Why?
|
Cost of Illness | 3 | 2021 | 1859 | 0.210 |
Why?
|
Vitiligo | 1 | 2022 | 89 | 0.200 |
Why?
|
Dermatitis | 1 | 2023 | 199 | 0.200 |
Why?
|
Respiration, Artificial | 1 | 2012 | 2568 | 0.190 |
Why?
|
Germ Cells | 2 | 2022 | 629 | 0.190 |
Why?
|
Lung Neoplasms | 2 | 2022 | 13112 | 0.190 |
Why?
|
Antineoplastic Agents | 1 | 2024 | 13691 | 0.190 |
Why?
|
Health Care Costs | 2 | 2013 | 3207 | 0.190 |
Why?
|
Facial Neoplasms | 1 | 2021 | 121 | 0.190 |
Why?
|
Aged | 22 | 2022 | 163178 | 0.180 |
Why?
|
Comorbidity | 6 | 2022 | 10380 | 0.180 |
Why?
|
Warts | 1 | 2020 | 68 | 0.180 |
Why?
|
Massachusetts | 3 | 2021 | 8660 | 0.180 |
Why?
|
Biological Factors | 1 | 2021 | 164 | 0.180 |
Why?
|
Male | 31 | 2022 | 349776 | 0.180 |
Why?
|
Eczema | 1 | 2022 | 231 | 0.180 |
Why?
|
Female | 33 | 2023 | 380020 | 0.170 |
Why?
|
Hydroxychloroquine | 1 | 2023 | 412 | 0.170 |
Why?
|
Antibodies, Monoclonal | 4 | 2023 | 9272 | 0.170 |
Why?
|
Sezary Syndrome | 1 | 2020 | 76 | 0.170 |
Why?
|
Skin Pigmentation | 1 | 2021 | 282 | 0.170 |
Why?
|
Mohs Surgery | 1 | 2021 | 197 | 0.170 |
Why?
|
Information Seeking Behavior | 1 | 2020 | 113 | 0.170 |
Why?
|
Stevens-Johnson Syndrome | 1 | 2022 | 281 | 0.160 |
Why?
|
Sentinel Lymph Node Biopsy | 1 | 2023 | 710 | 0.160 |
Why?
|
Cost-Benefit Analysis | 5 | 2017 | 5388 | 0.160 |
Why?
|
Incidence | 5 | 2023 | 20948 | 0.150 |
Why?
|
Databases, Factual | 3 | 2022 | 7729 | 0.150 |
Why?
|
Canada | 2 | 2020 | 2064 | 0.150 |
Why?
|
Adult | 20 | 2023 | 213889 | 0.150 |
Why?
|
Renin-Angiotensin System | 1 | 2022 | 758 | 0.150 |
Why?
|
Middle Aged | 21 | 2021 | 213241 | 0.150 |
Why?
|
Risk Factors | 8 | 2023 | 72252 | 0.150 |
Why?
|
Lymph Node Excision | 1 | 2023 | 1262 | 0.150 |
Why?
|
Prevalence | 5 | 2020 | 15211 | 0.140 |
Why?
|
Carcinoma, Basal Cell | 1 | 2021 | 545 | 0.130 |
Why?
|
Cholesteatoma, Middle Ear | 1 | 2015 | 49 | 0.130 |
Why?
|
Mastoid | 1 | 2015 | 92 | 0.130 |
Why?
|
Tympanoplasty | 1 | 2015 | 71 | 0.130 |
Why?
|
Dermatitis, Atopic | 1 | 2022 | 654 | 0.130 |
Why?
|
Educational Status | 2 | 2013 | 2540 | 0.120 |
Why?
|
Logistic Models | 4 | 2019 | 13404 | 0.120 |
Why?
|
Ligands | 1 | 2022 | 3281 | 0.120 |
Why?
|
Hodgkin Disease | 1 | 2022 | 1415 | 0.120 |
Why?
|
Dermatologic Agents | 1 | 2017 | 278 | 0.120 |
Why?
|
Neck Pain | 1 | 2014 | 180 | 0.110 |
Why?
|
Otitis Media | 1 | 2015 | 277 | 0.110 |
Why?
|
Tetracycline | 2 | 2023 | 214 | 0.110 |
Why?
|
Inpatients | 2 | 2021 | 2515 | 0.110 |
Why?
|
Hospital Charges | 1 | 2014 | 362 | 0.100 |
Why?
|
Space Perception | 1 | 2015 | 474 | 0.100 |
Why?
|
Minocycline | 2 | 2023 | 163 | 0.100 |
Why?
|
Maryland | 1 | 2012 | 276 | 0.100 |
Why?
|
Urinary Catheterization | 1 | 2013 | 201 | 0.100 |
Why?
|
Baltimore | 3 | 2018 | 230 | 0.100 |
Why?
|
Lymph Nodes | 1 | 2023 | 3476 | 0.100 |
Why?
|
Drug Approval | 1 | 2018 | 742 | 0.100 |
Why?
|
Language Development | 1 | 2012 | 186 | 0.100 |
Why?
|
Developmental Disabilities | 1 | 2019 | 1452 | 0.100 |
Why?
|
Confidence Intervals | 2 | 2018 | 2971 | 0.100 |
Why?
|
Treatment Outcome | 11 | 2021 | 63042 | 0.100 |
Why?
|
Neck Dissection | 1 | 2012 | 197 | 0.100 |
Why?
|
Antiviral Agents | 1 | 2023 | 2984 | 0.100 |
Why?
|
Hepatectomy | 1 | 2014 | 550 | 0.090 |
Why?
|
Cochlear Nerve | 1 | 2012 | 197 | 0.090 |
Why?
|
Postural Balance | 1 | 2015 | 621 | 0.090 |
Why?
|
Patient Acceptance of Health Care | 2 | 2021 | 3020 | 0.090 |
Why?
|
Hematologic Neoplasms | 1 | 2022 | 1832 | 0.090 |
Why?
|
Pneumonia | 1 | 2022 | 2133 | 0.090 |
Why?
|
Accidental Falls | 2 | 2015 | 1062 | 0.090 |
Why?
|
Sequence Analysis, DNA | 1 | 2021 | 4803 | 0.090 |
Why?
|
Catheter-Related Infections | 1 | 2013 | 252 | 0.090 |
Why?
|
Socioeconomic Factors | 2 | 2021 | 7784 | 0.090 |
Why?
|
Vaccination | 1 | 2022 | 3275 | 0.090 |
Why?
|
Steroids | 1 | 2014 | 930 | 0.090 |
Why?
|
Colectomy | 1 | 2014 | 680 | 0.080 |
Why?
|
Risk Assessment | 4 | 2021 | 23327 | 0.080 |
Why?
|
Self Report | 1 | 2020 | 3550 | 0.080 |
Why?
|
Internet | 2 | 2018 | 3058 | 0.080 |
Why?
|
Pain | 2 | 2020 | 4987 | 0.080 |
Why?
|
Healthcare Disparities | 2 | 2021 | 3155 | 0.080 |
Why?
|
Odds Ratio | 3 | 2018 | 9848 | 0.080 |
Why?
|
Aging | 2 | 2016 | 8655 | 0.070 |
Why?
|
Visual Perception | 1 | 2015 | 1414 | 0.070 |
Why?
|
Genome-Wide Association Study | 2 | 2022 | 12259 | 0.070 |
Why?
|
Urinary Tract Infections | 1 | 2013 | 788 | 0.070 |
Why?
|
Academic Medical Centers | 2 | 2018 | 2760 | 0.070 |
Why?
|
Activities of Daily Living | 1 | 2015 | 2419 | 0.070 |
Why?
|
Vestibular Function Tests | 2 | 2016 | 127 | 0.070 |
Why?
|
Postoperative Care | 1 | 2012 | 1485 | 0.070 |
Why?
|
Age of Onset | 1 | 2012 | 3268 | 0.070 |
Why?
|
Neoplasm Recurrence, Local | 1 | 2023 | 9239 | 0.060 |
Why?
|
Chronic Disease | 4 | 2022 | 9139 | 0.060 |
Why?
|
Delivery of Health Care | 1 | 2023 | 5319 | 0.060 |
Why?
|
Hospital Mortality | 3 | 2013 | 5316 | 0.060 |
Why?
|
Attention Deficit Disorder with Hyperactivity | 1 | 2019 | 3655 | 0.060 |
Why?
|
Radioimmunotherapy | 1 | 2024 | 91 | 0.060 |
Why?
|
Longitudinal Studies | 3 | 2016 | 13980 | 0.060 |
Why?
|
Physicians | 1 | 2022 | 4569 | 0.060 |
Why?
|
Photogrammetry | 1 | 2023 | 73 | 0.060 |
Why?
|
Neoplasm Staging | 1 | 2018 | 11036 | 0.060 |
Why?
|
Carcinoma, Non-Small-Cell Lung | 1 | 2022 | 5230 | 0.060 |
Why?
|
Genetic Predisposition to Disease | 2 | 2023 | 17439 | 0.060 |
Why?
|
Bone Density | 1 | 2016 | 3460 | 0.060 |
Why?
|
Health Status | 2 | 2014 | 4031 | 0.060 |
Why?
|
Pandemics | 1 | 2023 | 8385 | 0.060 |
Why?
|
Venous Thrombosis | 1 | 2012 | 1240 | 0.050 |
Why?
|
Child, Preschool | 3 | 2019 | 40964 | 0.050 |
Why?
|
Aged, 80 and over | 6 | 2021 | 57744 | 0.050 |
Why?
|
Lactate Dehydrogenases | 1 | 2022 | 26 | 0.050 |
Why?
|
Interleukin-7 | 1 | 2022 | 142 | 0.050 |
Why?
|
Religion and Sex | 1 | 2021 | 2 | 0.050 |
Why?
|
Doxycycline | 1 | 2023 | 326 | 0.050 |
Why?
|
Multivariate Analysis | 2 | 2012 | 12243 | 0.050 |
Why?
|
Time Factors | 2 | 2021 | 40038 | 0.050 |
Why?
|
Survival Rate | 2 | 2012 | 12786 | 0.050 |
Why?
|
Biological Therapy | 1 | 2022 | 138 | 0.050 |
Why?
|
Vitamin B 6 | 1 | 2022 | 236 | 0.050 |
Why?
|
Catheter Ablation | 1 | 2014 | 2758 | 0.050 |
Why?
|
Age Factors | 2 | 2018 | 18355 | 0.050 |
Why?
|
Surgical Procedures, Operative | 1 | 2012 | 1877 | 0.050 |
Why?
|
Prospective Studies | 4 | 2023 | 53250 | 0.040 |
Why?
|
Severity of Illness Index | 2 | 2018 | 15526 | 0.040 |
Why?
|
Liver Neoplasms | 1 | 2014 | 4251 | 0.040 |
Why?
|
Case-Control Studies | 3 | 2022 | 21733 | 0.040 |
Why?
|
Health Surveys | 2 | 2020 | 4036 | 0.040 |
Why?
|
Lymphocytes, Tumor-Infiltrating | 1 | 2023 | 1038 | 0.040 |
Why?
|
Isotretinoin | 1 | 2017 | 114 | 0.040 |
Why?
|
Adolescent | 6 | 2023 | 85729 | 0.040 |
Why?
|
Delayed Diagnosis | 1 | 2019 | 441 | 0.030 |
Why?
|
Length of Stay | 3 | 2014 | 6311 | 0.030 |
Why?
|
Mental Disorders | 1 | 2015 | 6593 | 0.030 |
Why?
|
Consensus | 1 | 2024 | 2954 | 0.030 |
Why?
|
Anti-Bacterial Agents | 2 | 2023 | 7172 | 0.030 |
Why?
|
Nortriptyline | 1 | 2014 | 81 | 0.030 |
Why?
|
Gene Frequency | 1 | 2021 | 3585 | 0.030 |
Why?
|
Cluster Analysis | 1 | 2021 | 2712 | 0.030 |
Why?
|
Colorectal Neoplasms | 1 | 2014 | 6773 | 0.030 |
Why?
|
Child | 3 | 2023 | 77637 | 0.030 |
Why?
|
Phenotype | 2 | 2022 | 16361 | 0.030 |
Why?
|
Cyclohexanecarboxylic Acids | 1 | 2014 | 141 | 0.030 |
Why?
|
Vitamins | 1 | 2022 | 1622 | 0.030 |
Why?
|
Product Surveillance, Postmarketing | 1 | 2018 | 430 | 0.030 |
Why?
|
Postoperative Complications | 2 | 2013 | 15281 | 0.030 |
Why?
|
Proto-Oncogene Proteins B-raf | 1 | 2023 | 2039 | 0.030 |
Why?
|
Neoplasm Invasiveness | 1 | 2021 | 3617 | 0.030 |
Why?
|
DNA Copy Number Variations | 1 | 2021 | 1937 | 0.030 |
Why?
|
Amines | 1 | 2014 | 276 | 0.030 |
Why?
|
Confusion | 1 | 2015 | 275 | 0.030 |
Why?
|
Injections, Epidural | 1 | 2014 | 195 | 0.030 |
Why?
|
Antidepressive Agents, Tricyclic | 1 | 2014 | 434 | 0.030 |
Why?
|
Drug Evaluation, Preclinical | 1 | 2018 | 1374 | 0.030 |
Why?
|
Infant | 1 | 2013 | 35122 | 0.020 |
Why?
|
Reference Values | 1 | 2018 | 4974 | 0.020 |
Why?
|
Physical Therapy Modalities | 1 | 2014 | 549 | 0.020 |
Why?
|
Temperature | 1 | 2017 | 2202 | 0.020 |
Why?
|
Alleles | 1 | 2021 | 6934 | 0.020 |
Why?
|
Imaging, Three-Dimensional | 1 | 2023 | 4033 | 0.020 |
Why?
|
Health Care Surveys | 1 | 2017 | 2453 | 0.020 |
Why?
|
United States Food and Drug Administration | 1 | 2018 | 1582 | 0.020 |
Why?
|
Drainage | 1 | 2015 | 1142 | 0.020 |
Why?
|
Computational Biology | 1 | 2021 | 3515 | 0.020 |
Why?
|
High-Throughput Nucleotide Sequencing | 1 | 2021 | 3591 | 0.020 |
Why?
|
Cost Savings | 1 | 2014 | 925 | 0.020 |
Why?
|
gamma-Aminobutyric Acid | 1 | 2014 | 1118 | 0.020 |
Why?
|
Vitamin D | 1 | 2022 | 3222 | 0.020 |
Why?
|
Prognosis | 2 | 2019 | 29052 | 0.020 |
Why?
|
Cervical Vertebrae | 1 | 2014 | 976 | 0.020 |
Why?
|
Residence Characteristics | 1 | 2018 | 2050 | 0.020 |
Why?
|
Memory Disorders | 1 | 2015 | 1186 | 0.020 |
Why?
|
Analgesics | 1 | 2014 | 1040 | 0.020 |
Why?
|
Young Adult | 3 | 2020 | 56392 | 0.020 |
Why?
|
Genotype | 1 | 2021 | 12944 | 0.020 |
Why?
|
Protein Kinase Inhibitors | 1 | 2023 | 5532 | 0.020 |
Why?
|
Disease Progression | 1 | 2023 | 13273 | 0.020 |
Why?
|
Regression Analysis | 1 | 2016 | 6457 | 0.020 |
Why?
|
Reproducibility of Results | 1 | 2023 | 19894 | 0.020 |
Why?
|
Cognition | 1 | 2022 | 6759 | 0.020 |
Why?
|
Pain Measurement | 1 | 2014 | 3420 | 0.020 |
Why?
|
Sex Factors | 1 | 2018 | 10394 | 0.010 |
Why?
|
Medicare | 1 | 2022 | 6565 | 0.010 |
Why?
|
Anxiety Disorders | 1 | 2015 | 2684 | 0.010 |
Why?
|
Polymorphism, Single Nucleotide | 1 | 2021 | 15518 | 0.010 |
Why?
|
Depressive Disorder | 1 | 2015 | 3744 | 0.010 |
Why?
|
Clinical Trials as Topic | 1 | 2018 | 7908 | 0.010 |
Why?
|
Research Design | 1 | 2018 | 5983 | 0.010 |
Why?
|
Hospitalization | 1 | 2021 | 10259 | 0.010 |
Why?
|
Pulmonary Embolism | 1 | 2012 | 2375 | 0.010 |
Why?
|
Mutation | 1 | 2021 | 29777 | 0.010 |
Why?
|
Follow-Up Studies | 1 | 2014 | 39001 | 0.010 |
Why?
|
Concepts
(250)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(88)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_